Analyst Price Target Update on McKesson Corporation (NYSE:MCK)

McKesson Corporation (NYSE:MCK): The stock price is expected to reach $ 194.46 in the short term. The number of analysts agreeing with this consensus is 11. The higher estimate for the short term price target is at $220 while the lower estimate is at $172. The standard deviation of the price stands at $16.35.

Many analysts have stated their opinion on the company shares. Bank of America reinstates their rating on the shares of McKesson Corporation (NYSE:MCK). The current rating of the shares is Neutral. The rating by the firm was issued on June 7, 2016. For the current week, the company shares have a recommendation consensus of Buy.

On the companys insider trading activities,The director officer (Chairman, President & CEO) of Mckesson Corp, Hammergren John H sold 37,420 shares at $182.87 on May 24, 2016. The Insider selling transaction had a total value worth of $6,842,995. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

McKesson Corporation (NYSE:MCK) stock ended Monday session in the red zone in a volatile trading. The stock closed down 1.83 points or 0.99% at $183.64 with 1,440,768 shares getting traded. Post opening the session at $185.67, the shares hit an intraday low of $183.47 and an intraday high of $186.56 and the price was in this range throughout the day. The company has a market cap of $41,323 million and the number of outstanding shares have been calculated to be 225,020,520 shares. The 52-week high of McKesson Corporation (NYSE:MCK) is $238.5 and the 52-week low is $148.29.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.